Spots Global Cancer Trial Database for mitomycin
Every month we try and update this database with for mitomycin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Sequential Combination Therapy in Bladder Cancer | NCT03790384 | Bladder Cancer | Mitomycin | 30 Years - | Azienda Ospedaliera "Sant'Andrea" | |
| Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection | NCT00816075 | Recurrent Super... Distilled Water | distilled water | - | Bozyaka Training and Research Hospital | |
| Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection | NCT02852564 | Bladder Cancer | Ethacrynic Acid | 18 Years - | University of Kansas Medical Center | |
| Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection | NCT00816075 | Recurrent Super... Distilled Water | distilled water | - | Bozyaka Training and Research Hospital | |
| A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer | NCT00190528 | Cervical Neopla... | neoadjuvant che... radical hystere... | 20 Years - 70 Years | Japan Clinical Oncology Group | |
| Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors | NCT01017640 | Solid Neoplasm | Laboratory Biom... Mitomycin Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer | NCT05243550 | Bladder Cancer Urothelial Carc... Urothelial Carc... | UGN-102 | 18 Years - | UroGen Pharma Ltd. | |
| Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor | NCT01511146 | Liver Metastasi... | Oxaliplatin Mitomycin + Gem... | 18 Years - | Copenhagen University Hospital at Herlev | |
| Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer | NCT03617913 | Bladder Carcino... Stage II Bladde... Stage II Renal ... Stage II Ureter... Stage II Urethr... Stage III Bladd... Stage III Renal... Stage III Urete... Stage III Ureth... Stage IIIA Blad... Stage IIIB Blad... Urethral Urothe... | Avelumab Cisplatin Fluorouracil Mitomycin Quality-of-Life... Radiation Thera... | 18 Years - | Mayo Clinic | |
| Precise Neoadjuvant Chemoresection of Low Grade NMIBC | NCT06227065 | Bladder Cancer Non-muscle Inva... Low-risk | Epirubicin Mitomycin Gemcitabine Docetaxel | 18 Years - | University of Bern | |
| SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I | NCT02254915 | Urinary Bladder... Urologic Neopla... Urogenital Neop... Neoplasms Neoplasms by Si... Urinary Bladder... Urologic Diseas... | Synergo + MMC Bacillus Calmet... | 18 Years - | Medical Enterprises Europe B.V. | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer | NCT04929028 | AIDS-Related An... Anal Basaloid S... Anal Canal Cloa... Anal Margin Squ... Anal Squamous C... HIV Infection Rectal Squamous... Stage I Anal Ca... Stage II Anal C... Stage II Rectal... Stage III Anal ... Stage III Recta... | Capecitabine Fluorouracil Intensity-Modul... Mitomycin Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | NCT03210298 | Peritoneum Canc... Peritoneum Neop... Pleural Cancer Pleural Effusio... Pleural Mesothe... Ovarian Cancer Gastric Cancer Appendix Cancer Pseudomyxoma Pe... Colorectal Canc... Pancreas Cancer Gallbladder Can... Ascites CUP Chemotherapeuti... | PIPAC | 10 Years - | University of Magdeburg | |
| International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | NCT03210298 | Peritoneum Canc... Peritoneum Neop... Pleural Cancer Pleural Effusio... Pleural Mesothe... Ovarian Cancer Gastric Cancer Appendix Cancer Pseudomyxoma Pe... Colorectal Canc... Pancreas Cancer Gallbladder Can... Ascites CUP Chemotherapeuti... | PIPAC | 10 Years - | University of Magdeburg | |
| Trial of Adjuvant Chemotherapy for Gastric Cancer | NCT00296322 | Stomach Cancer | cisplatin, mito... | 18 Years - 69 Years | Asan Medical Center | |
| Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC) | NCT05136898 | Bladder Cancer Urothelial Carc... Urothelial Carc... | UGN-102 | 18 Years - | UroGen Pharma Ltd. | |
| A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer | NCT05243550 | Bladder Cancer Urothelial Carc... Urothelial Carc... | UGN-102 | 18 Years - | UroGen Pharma Ltd. | |
| Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis | NCT00454519 | Stomach Neoplas... Colorectal Neop... Neoplasm Metast... Mesothelioma | cytoreductive s... intraoperative ... | 20 Years - 70 Years | Wuhan University | |
| PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer | NCT04329494 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Malignant Uteri... Metastatic Appe... Metastatic Colo... Metastatic Gast... Metastatic Mali... Metastatic Mali... Metastatic Ovar... Pathologic Stag... Peritoneal Carc... Postneoadjuvant... Stage IV Append... Stage IV Colore... Stage IV Ovaria... Stage IV Uterin... Stage IVA Appen... Stage IVA Color... Stage IVA Ovari... Stage IVA Uteri... Stage IVB Appen... Stage IVB Color... Stage IVB Ovari... Stage IVB Uteri... Stage IVC Appen... Stage IVC Color... | Biopsy Cisplatin Doxorubicin Fluorouracil Intraperitoneal... Irinotecan Leucovorin Mitomycin Oxaliplatin Quality-of-Life... Questionnaire A... | 18 Years - | City of Hope Medical Center | |
| Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer | NCT00981656 | Bladder Cancer | cisplatin 5-fluorouracil Mitomycin Three-Dimension... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer | NCT01442519 | Bladder Cancer | bacillus Calmet... electromotive m... | 18 Years - 90 Years | University of Rome Tor Vergata | |
| A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer | NCT03558503 | Bladder Cancer Urothelial Carc... Urothelial Carc... | UGN-102 | 18 Years - | UroGen Pharma Ltd. | |
| Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer | NCT04107077 | Gastric Cancer Peritoneal Carc... | Cisplatin Mitomycin | 18 Years - | University of Chicago | |
| Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal | NCT01843452 | Carcinoma of An... | RADIOTHERAPY PANITUMUMAB MITOMYCIN CAPECITABINE | 18 Years - | Centre Hospitalier Universitaire Vaudois | |
| A Phase 3 Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer | NCT04688931 | Bladder Cancer Urothelial Carc... Urothelial Carc... | UGN-102 TURBT | 18 Years - | UroGen Pharma Ltd. | |
| Named Patient Program for Mitomycin for Pyelocalyceal Solution | NCT05494411 | Urothelial Canc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... | Mitomycin for p... | 18 Years - | UroGen Pharma Ltd. | |
| Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer | NCT02891447 | Gastric Adenoca... Gastroesophagea... Peritoneal Carc... | Cisplatin Hyperthermic In... Mitomycin | 18 Years - | M.D. Anderson Cancer Center | |
| Trial of Adjuvant Chemotherapy for Gastric Cancer | NCT00296322 | Stomach Cancer | cisplatin, mito... | 18 Years - 69 Years | Asan Medical Center | |
| Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer | NCT04107077 | Gastric Cancer Peritoneal Carc... | Cisplatin Mitomycin | 18 Years - | University of Chicago | |
| Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study | NCT04166318 | Anal Basaloid C... Anal Canal Cloa... Anal Canal Squa... Anal Margin Squ... Stage I Anal Ca... Stage IIA Anal ... | Capecitabine Fluorouracil Intensity-Modul... Mitomycin Quality-of-Life... Questionnaire A... | 18 Years - | Eastern Cooperative Oncology Group | |
| Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer | NCT03617913 | Bladder Carcino... Stage II Bladde... Stage II Renal ... Stage II Ureter... Stage II Urethr... Stage III Bladd... Stage III Renal... Stage III Urete... Stage III Ureth... Stage IIIA Blad... Stage IIIB Blad... Urethral Urothe... | Avelumab Cisplatin Fluorouracil Mitomycin Quality-of-Life... Radiation Thera... | 18 Years - | Mayo Clinic | |
| A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer | NCT03558503 | Bladder Cancer Urothelial Carc... Urothelial Carc... | UGN-102 | 18 Years - | UroGen Pharma Ltd. | |
| ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis | NCT01815359 | Appendix Cancer Colorectal Canc... | Cytoreductive S... HIPEC with Mito... EPIC with FUDR ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer | NCT02311101 | Urinary Bladder... | Mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer | NCT00190528 | Cervical Neopla... | neoadjuvant che... radical hystere... | 20 Years - 70 Years | Japan Clinical Oncology Group | |
| Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer | NCT03775265 | Bladder Urothel... Muscle Invasive... Stage II Bladde... Stage IIIA Blad... | Atezolizumab Biopsy of Bladd... Cisplatin Computed Tomogr... Cystoscopy Fluorouracil Gemcitabine Magnetic Resona... Mitomycin Quality-of-Life... Radiation Thera... Survey Administ... Transurethral R... | 18 Years - | National Cancer Institute (NCI) | |
| Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | NCT01004978 | Hepatocellular ... Unresectable He... | Cisplatin Computed Tomogr... Doxorubicin Hyd... Doxorubicin-Elu... Laboratory Biom... Magnetic Resona... Mitomycin Pharmacological... Placebo Adminis... Sorafenib Tosyl... | 18 Years - | National Cancer Institute (NCI) | |
| Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer | NCT02311101 | Urinary Bladder... | Mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer | NCT02311101 | Urinary Bladder... | Mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer | NCT06331299 | Bladder Cancer Urothelial Carc... Urothelial Carc... | UGN-103 | 18 Years - | UroGen Pharma Ltd. | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors | NCT01017640 | Solid Neoplasm | Laboratory Biom... Mitomycin Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) | NCT01799499 | Non Muscle Inva... | TC-3 hydrogel TC-3 hydrogel TC-3 hydrogel | 21 Years - | UroGen Pharma Ltd. | |
| Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer | NCT01442519 | Bladder Cancer | bacillus Calmet... electromotive m... | 18 Years - 90 Years | University of Rome Tor Vergata | |
| A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer | NCT05243550 | Bladder Cancer Urothelial Carc... Urothelial Carc... | UGN-102 | 18 Years - | UroGen Pharma Ltd. | |
| Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids | NCT05024734 | Bladder Cancer Non-muscle Inva... | Epirubicin Mitomycin Gemcitabine Docetaxel | 18 Years - | Insel Gruppe AG, University Hospital Bern | |
| Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC) | NCT05250648 | Peritoneal Carc... Colon Cancer | complete cytore... complete cytore... | 18 Years - | Hospital Universitario de Fuenlabrada | |
| Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study. | NCT03914820 | Colorectal Neop... | HIPEC CO2 surge... Standard surger... Mitomycin | 18 Years - 75 Years | Mario Negri Institute for Pharmacological Research | |
| Named Patient Program for Mitomycin for Pyelocalyceal Solution | NCT05494411 | Urothelial Canc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... | Mitomycin for p... | 18 Years - | UroGen Pharma Ltd. | |
| SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I | NCT02254915 | Urinary Bladder... Urologic Neopla... Urogenital Neop... Neoplasms Neoplasms by Si... Urinary Bladder... Urologic Diseas... | Synergo + MMC Bacillus Calmet... | 18 Years - | Medical Enterprises Europe B.V. | |
| Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma | NCT01171482 | Carcinoma, Hepa... | 5-FU Mitomycin sorafenib | 20 Years - 80 Years | Seoul National University Hospital | |
| Trial of Adjuvant Chemotherapy for Gastric Cancer | NCT00296322 | Stomach Cancer | cisplatin, mito... | 18 Years - 69 Years | Asan Medical Center | |
| HIPEC After Radical Cystectomy for High Risk Bladder Cancer | NCT03514888 | Invasive Bladde... | HIPEC | 45 Years - 85 Years | Weill Medical College of Cornell University | |
| A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer | NCT01671488 | Anal Cancer | Treatment 5FU Mitomycin IMRT | 18 Years - | Brown University | |
| Transarterial Chemoembolization for the Treatment of Lung Cancer | NCT05672108 | Lung Non-Small ... Mediastinal Neo... Pleural Neoplas... | Computed Tomogr... Ethiodized Oil Mitomycin Transarterial C... Tris-acryl Gela... | 18 Years - | City of Hope Medical Center | |
| Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer | NCT02092298 | Gastrointestina... | Mitomycin C Cisplatin Sodium Thiosulf... | 18 Years - | M.D. Anderson Cancer Center | |
| Trial of Adjuvant Chemotherapy for Gastric Cancer | NCT00296335 | Stomach Cancer | Mitomycin, doxi... Mitomycin and d... | 18 Years - 69 Years | Asan Medical Center | |
| Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver | NCT00003907 | Liver Cancer Metastatic Canc... | cisplatin doxorubicin mitomycin embolization | 18 Years - | Eastern Cooperative Oncology Group | |
| Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection | NCT02852564 | Bladder Cancer | Ethacrynic Acid | 18 Years - | University of Kansas Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
